XBiotech Announces First Patient Enrolled in Randomized Multi-Center Clinical Study Evaluating Bermekimab Therapy in Patients with Hidradenitis Suppurativa

Press/Media

Period	23 Oct 2019

Media coverage

Title	XBiotech Announces First Patient Enrolled in Randomized Multi-Center Clinical Study Evaluating Bermekimab Therapy in Patients with Hidradenitis Suppurativa
Media name/outlet	APNews.com
Country/Territory	United States
Date	23/10/19
URL	https://www.apnews.com/Globe%20Newswire/8204bbc6a670037cfaf654a8a27cf125
Persons	Alice Gottlieb